This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Brand Names
- Adacel, Boostrix, Daptacel, Diphtheria and Tetanus Toxoids Adsorbed, Infanrix, Kinrix, Nimenrix, Pediarix, Pentacel, Quadracel, Td Adsorbed, Tdvax, Tenivac, Vaxelis
- Generic Name
- Clostridium tetani toxoid antigen (formaldehyde inactivated)
- DrugBank Accession Number
- DB10583
- Background
Clostridium tetani toxoid antigen (formaldehyde inactivated) is a vaccine for intramuscular injection. It is used for active immunization of children 7 years of age or older, and adults, for prevention of tetanus. The toxoid in the Clostridium tetani culture is grown and detoxified followed by purification via ammonium sulfate filtration and precipation.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Vaccines
Inactivated / Toxoid - Synonyms
- Tetanus toxoid
- Tetanus toxoid adsorbed
- tetanus toxoid vaccine, inactivated
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Associated Therapies
- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAbatacept The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Abatacept. Adalimumab The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab. Aldesleukin The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin. Alefacept The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Alefacept. Alemtuzumab The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Alemtuzumab. Altretamine The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Altretamine. Amsacrine The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Amsacrine. Anakinra The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra. Anifrolumab The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Anifrolumab. Antilymphocyte immunoglobulin (horse) The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Antilymphocyte immunoglobulin (horse). 
Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Tetanus Toxoid Adsorbed Injection, suspension 5 [Lf]/0.5mL Intramuscular Sanofi Pasteur Inc. 2005-09-23 2016-04-14 US 
Tetanus Toxoid Adsorbed Suspension 5 lf / 0.5 mL Intramuscular ID Biomedical Corporation of Quebec 1991-12-31 2005-08-03 Canada 
Tetanus Toxoid Adsorbed Injection, suspension 5 [Lf]/0.5mL Intramuscular Sanofi Pasteur Inc. 2005-09-23 2016-04-14 US Tetanus Toxoid Adsorbed Inj Liquid 5 lf / 0.5 mL Intramuscular Aventis Pasteur Limited 1980-12-31 2006-07-17 Canada - Mixture Products
Categories
- ATC Codes
- J07AM51 — Tetanus toxoid, combinations with diphtheria toxoidJ07AM01 — Tetanus toxoidJ07AM52 — Tetanus toxoid, combinations with tetanus immunoglobulin
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- K3W1N8YP13
- CAS number
- Not Available
References
- General References
- TITCK Product Information: Tetadif (purified diphtheria/tetanus toxoid) for injection [Link]
- External Links
Clinical Trials
- Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, suspension 40 iu/0.5ml Injection, suspension Intramuscular 0.5 ml Injection Suspension Intramuscular Injection, suspension Intramuscular Liquid Intramuscular Injection, suspension Parenteral Injection, suspension Intramuscular 40 IU/0.5ml Injection, powder, for suspension Intramuscular Solution Intramuscular Kit; powder, for solution Intramuscular Injection, powder, for solution Intramuscular Injection; injection, suspension; kit Intramuscular Injection, solution Intramuscular Injection, solution Intramuscular Suspension Intramuscular Injection, suspension Intramuscular 5 [Lf]/0.5mL Suspension Intramuscular 5 lf / 0.5 mL Liquid Intramuscular 5 lf / 0.5 mL Injection, suspension Intramuscular Injection, suspension Intramuscular; Subcutaneous 40 IU Suspension Intramuscular; Subcutaneous 40 I.U/ 0.5ml dose Injection, suspension Intramuscular 30 iu/0.5ml Injection, suspension Intramuscular; Subcutaneous Injection Intramuscular 30 iu/0.5ml Injection Intramuscular Suspension Intramuscular 10 LfU Injection Injection, suspension Injection 40 iu/0.5ml Injection, suspension 10 Lf/0.5ml - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at May 26, 2023 16:43